Karnataka Antibiotics AND Pharmaceuticals Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Karnataka Antibiotics AND Pharmaceuticals Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $3.8M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Karnataka Antibiotics AND Pharmaceuticals Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $3.8M Trade | TransData Nexus

Karnataka Antibiotics AND Pharmaceuticals Limited

Indian Pharmaceutical Exporter · Antibiotics Specialist · $3.8M Total Trade · DGFT Verified

Karnataka Antibiotics AND Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $3.8M across 2 products in 2 therapeutic categories. Based on 161 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ampicillin ($3.1M), Benzylpenicillin ($744.6K), .

Karnataka Antibiotics AND Pharmaceuticals Limited — Export Portfolio & Destination Treemap

Karnataka Antibiotics AND Pharmaceuticals Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Karnataka Antibiotics AND Pharmaceuticals Limited? — Company Overview & Market Position

Karnataka Antibiotics & Pharmaceuticals Limited (KAPL) is a public sector enterprise established on March 13, 1981, in Bengaluru, Karnataka, India. The company commenced commercial production in August 1984, focusing on the manufacturing of pharmaceutical formulations such as tablets, capsules, and injectables. Initially a joint sector undertaking between Hindustan Antibiotics Limited (HAL) and the Karnataka State Industrial and Investment Development Corporation (KSIIDC), HAL's shares were transferred to the Government of India in 2009, resulting in the government holding a 59% equity stake, with KSIIDC owning the remaining 41%.

As of March 31, 2023, KAPL reported a paid-up capital of ₹13.49 crore (approximately $1.8 million USD). The company's registered office is located at Arka The Business Centre, Plot No. 37, Site No. 34/4, NTTF Main Road, Peenya Industrial Area, Bengaluru, Karnataka 560058, India. KAPL has consistently been a profit-making organization since its inception and is recognized as a Memorandum of Understanding (MoU) signing company.

What Does Karnataka Antibiotics AND Pharmaceuticals Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ampicillin$3.1M

Product Portfolio — Top 2 by Export Value

Karnataka Antibiotics AND Pharmaceuticals Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ampicillin	Antibiotics	$3.1M	103	2.2%	8
2	Benzylpenicillin	Advanced Antibiotics	$744.6K	58	19.4%	2

Karnataka Antibiotics AND Pharmaceuticals Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $3.8M. The top category is Antibiotics (80.6% of portfolio), followed by Advanced Antibiotics (19.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Karnataka Antibiotics AND Pharmaceuticals Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

KAPL operates manufacturing units in Bengaluru, Karnataka, where it produces a range of pharmaceutical formulations, including tablets, capsules, and injectables. The facilities are approved by various international regulatory bodies, ensuring compliance with global quality standards. Specific details regarding the capacities and specializations of these manufacturing plants are not publicly disclosed.

3Key Leadership

The current Managing Director of KAPL is Shri Sunil Kumar Kaimal. The company's board of directors includes:

Shri Mahammed Ariz Ahammed
Shri Jawaid Akhtar
Shri Jayaram Narasimhaiah
Shri Krishnamohanprasad
Shri Shalini Rajneesh
Shri Nirja Saraf
Shri Jitendra Trivedi
Shri Tayappa Khanapure Bhagoji
Shri Gunjan Kinnu
Shri Ajay Seth

These directors bring diverse expertise to the company's strategic and operational decision-making processes.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Karnataka Antibiotics AND Pharmaceuticals Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

KAPL's export portfolio, valued at $3.8 million USD over 161 shipments, comprises two products across two therapeutic categories. The top five products include Ampicillin ($3.1 million USD, 2.2% market share) and Benzylpenicillin ($745,000 USD, 19.4% market share). The primary therapeutic categories are Antibiotics (80.6%) and Advanced Antibiotics (19.4%). Notably, Benzylpenicillin holds a significant market share, indicating a strong presence in the global antibiotics market.

2Emerging Markets

KAPL's export data indicates a focus on markets where antibiotics are in high demand. While specific details about the company's penetration in Africa, Latin America, and Southeast Asia are not publicly available, the substantial market share of Benzylpenicillin suggests a strategic approach to regions with significant antibiotic consumption. The company's adherence to WHO-GMP standards and ISO certifications further enhance its credibility in these emerging markets.

3Geographic Strategy

KAPL's export strategy appears concentrated on a limited product range, with the top five products accounting for 100% of its export value. This concentration may expose the company to risks associated with market fluctuations and regulatory changes affecting these specific products. Diversifying its product portfolio and exploring new therapeutic areas could mitigate such risks and open avenues for growth in various global markets.

Karnataka Antibiotics AND Pharmaceuticals Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding KAPL's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed. The company's adherence to WHO-GMP standards and ISO certifications suggests a commitment to quality that aligns with international regulatory expectations.

2WHO & EU GMP

KAPL is a WHO-GMP certified organization, indicating compliance with the World Health Organization's Good Manufacturing Practices. Additionally, the company holds ISO certifications, reflecting its commitment to quality and services in both domestic and international markets.

3CDSCO & Indian Regulatory

KAPL operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company's manufacturing facilities are approved by various international regulatory bodies, ensuring compliance with global quality standards.

Karnataka Antibiotics AND Pharmaceuticals Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

KAPL operates in the competitive antibiotics market, with its top products being Ampicillin and Benzylpenicillin. While specific market share data for competitors in these categories is not provided, the company's significant export value and market share in Benzylpenicillin indicate a strong position. To maintain and enhance its competitive edge, KAPL may consider expanding its product portfolio and exploring new therapeutic areas.

2Key Differentiators

KAPL's adherence to WHO-GMP standards and ISO certifications underscores its commitment to quality and regulatory compliance. The company's focus on antibiotics, particularly Ampicillin and Benzylpenicillin, positions it as a specialized player in the global antibiotics market. These differentiators contribute to KAPL's reputation and reliability as a pharmaceutical exporter.

3Strategic Position

KAPL's current strategic direction appears focused on the production and export of antibiotics, with a particular emphasis on Ampicillin and Benzylpenicillin. The company's adherence to international quality standards positions it well in the global market. Future strategic initiatives could include diversifying its product portfolio, exploring new therapeutic areas, and expanding into emerging markets to drive growth and mitigate risks associated with market concentration.

Buyer Due Diligence Brief — Evaluating Karnataka Antibiotics AND Pharmaceuticals Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

KAPL's export data indicates a consistent volume of shipments, with 161 shipments valued at $3.8 million USD. The company's adherence to WHO-GMP standards and ISO certifications reflects a commitment to quality and reliability. These factors suggest that KAPL is a dependable supplier in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Indicates compliance with the World Health Organization's Good Manufacturing Practices. Verification can be done through the WHO's official website or by contacting KAPL directly.

ISO Certifications: Reflects adherence to international quality standards. Verification can be conducted by reviewing KAPL's official documentation or contacting the company for certification details.

3Due Diligence Checklist

Frequently Asked Questions — Karnataka Antibiotics AND Pharmaceuticals Limited

How many pharmaceutical products does Karnataka Antibiotics AND Pharmaceuticals Limited export from India?

Karnataka Antibiotics AND Pharmaceuticals Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Ampicillin ($3.1M), Benzylpenicillin ($744.6K). Total export value is $3.8M.

What is Karnataka Antibiotics AND Pharmaceuticals Limited's total pharmaceutical export value?

Karnataka Antibiotics AND Pharmaceuticals Limited's total pharmaceutical export value is $3.8M, based on 161 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Karnataka Antibiotics AND Pharmaceuticals Limited cover?

Karnataka Antibiotics AND Pharmaceuticals Limited exports across 2 therapeutic categories. The largest are Antibiotics (80.6%, 1 products), Advanced Antibiotics (19.4%, 1 products).

Get Full Karnataka Antibiotics AND Pharmaceuticals Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.